New York, NY -- (ReleaseWire) -- 01/23/2013 --AmarantusBioScience Inc. (OTCQB:AMBS) announced publication of independent peer-reviewed data for receptor and secretion pathways related to MANF
“This publication provides further insight into the biological profile of MANF and the proteins it interacts with in both an autocrine and paracrine fashion,” said Gerald E. Commissiong, President & CEO of Amarantus. “As we learn more about its biological functions, we believe the Company is likely to find additional avenues to commercially exploit MANF’s breakthrough biology, and bring new meaningful treatments to patients in a variety of indications, including orphan indications.”
AMBS owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders.
Find out where AMBS could be headed by getting the free full report here: http://www.monstertradingalerts.com/market-scan/?symbol=AMBS
AimHighProfits initiated coverage on Wuhan General Group China Inc. (OTCQB:WUHN). WUHN was up 672.15% in the last traded session and closed at $0.305. The stock moved up $ 0.266 on volume of 4.65M versus a 30 day average volume of 6,467.00.
Through its subsidiaries, Wuhan Blower, Wuhan Generating and Wuhan Sungreen, Wuhan General is a leading manufacturer of industrial blowers and turbines in China and the Company is based in Wuhan, Hubei Province, China. Wuhan Blower is a China-based manufacturer of industrial blowers that are principal components of steam-driven electrical power generation plants. Wuhan Generating is a China-based manufacturer of industrial steam and water turbines used for electricity generation in coal, oil, nuclear and hydroelectric power plants.
Find out more on WUHN by getting the free full report here:
MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www. MonsterTradingAlerts.com
Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
Alexander K. Neumann
Monster Trading Alerts